Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

FDA APPROVES BLOOD SUBSTITUTE TESTS

Oct. 30, 1991

ALLIANCE IMAGING AGENT ENTERS PHASE I

Oct. 30, 1991

CAL BIO RAISES $56.9 MILLION IN OFFERING

Oct. 30, 1991

ANALYST UPGRADES IMMUNEX RATING

Oct. 30, 1991

MAGAININ FILES FOR 2 MILLION-SHARE IPO

Oct. 30, 1991

IMMUNE RESPONSE RAISES $44 MILLION

Oct. 30, 1991

GENENTECH SEEKS BUYER FOR GLC ASSOCIATES

Oct. 30, 1991

XOMA WILL TRY TO BLOCK CENTOXIN

Oct. 30, 1991

GLAXO, AMYLIN TO CO-DEVELOP DIABETES DRUGS

Oct. 30, 1991

JURY RULES FOR XOMA IN PATENT DISPUTE

Oct. 29, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...